Skip to search boxSkip to navigationSkip to main content

A higher degree of expression of DNA methyl transferase 1 in cervical cancer is associated with poor survival outcome

  • Chandrika J Piyathilake
    ,
  • Suguna Badiga
    ,
  • Samuel G Borak
    ,
  • Janaka Weragoda
    ,
  • ,
  • Roland Matthews
  • Department of Nutrition Sciences
    ,
  • Department of Pathology
    ,
  • The University of Alabama at Birmingham
    ,
  • Department of Medicine
    ,
  • Morehouse School of Medicine
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

BACKGROUND: Even though novel therapies based on aberrant DNA methylation could be of particular importance for the treatment of cervical cancer (CC) because the oncoproteins E6/E7 of high-risk human papillomaviruses, the causative agents for developing CC, have the capacity to bind and upregulate DNA methyltransferases (DNMTs), to our knowledge, no previous studies have evaluated the expression of this enzyme in CC in relation to survival outcomes. The purpose of the study was to evaluate the expression of DNMT1 in CC and its association with survival outcomes.

METHODS: The study population consisted of 76 women treated for primary CC and followed up by the University of Alabama at Birmingham (UAB) cancer registry. The expression of DNMT1 was examined using immunohistochemistry, and the degree of expression of DNMT1 was expressed as a percentage of cells positive for DNMT1 and its intensity. Cox proportional hazards model was used to assess the relationship between the degree of expression of DNMT1 and overall survival after adjusting for relevant covariates.

RESULTS: The expression of DNMT1 was significantly higher in CC cells compared to that in the normal cervical epithelium. A higher percentage of cells positive for DNMT1 and a higher intensity score for DNMT1 were significantly associated with poor survival outcome (hazard ratio [HR] =4.3, P=0.03 and HR =4.9, P=0.02, respectively).

CONCLUSION: Our findings suggested that the degree of expression of DNMT1 could be considered as a target in the epigenetic treatment of CC. Replication of our results in other study populations with CC could create the opportunity of using DNMT inhibitors to treat CC.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 413-420 (8 pages)

Journal (Volume, Issue Number)

International Journal of Women's Health (Volume 9)

Publication milestones

  • Published - 2017

Publication status

Published - 2017

ISSN

1179-1411

Publication IDs

  • PubMed: 28652820
  • Scopus: 85021406117
  • ORCID: /0000-0001-9982-3223/work/189510653

Publication metrics

Metrics

Fractional count
1
Fractional count
0.13
Fractional count
7
Fractional count
0.88
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Citation count
30
Captures
32